Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD)

Clinical trial NCT00967096 · COMPLETED

Trial details

NCT number: NCT00967096
Sponsor: Emory University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignancy Bone Marrow Transplantation

Start date: 2007-04-01
Primary completion: 2009-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.